Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Irritable Bowel Syndrome01:23

Irritable Bowel Syndrome

DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment outcomes and predictors of macrophage activation syndrome in adult-onset Still's disease: a 24 year single-centre experience.

Scandinavian journal of rheumatology·2026
Same author

Evaluation of therapeutic plasma exchange in anti-neutrophil cytoplasmic antibody-associated vasculitis in real-life settings: long-term results of propensity score matching analysis in high-risk patients.

Scandinavian journal of rheumatology·2025
Same author

Infliximab as successful treatment option in a case of adenosine deaminase 2 deficiency.

Reumatismo·2023
Same author

Juvenile and adult-onset scleroderma: Different clinical phenotypes.

Seminars in arthritis and rheumatism·2023
Same author

Patients with rheumatic diseases are ready to use social media in clinical practice; what about rheumatologists? A cross-sectional survey.

Rheumatology international·2021
Same author

Apremilast to treat oral ulcers in Behçet syndrome.

Drugs of today (Barcelona, Spain : 1998)·2020

Related Experiment Video

Updated: May 21, 2026

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

Behçet syndrome: is it one condition?

H Yazici1, S Ugurlu, E Seyahi

  • 1Department of Medicine, Division of Rheumatology, Cerrahpaşa Medical School, University of Istanbul, Safa sok. 17/7 Kadikoy, Istanbul, 34710, Turkey. hasan@yazici.net

Clinical Reviews in Allergy & Immunology
|June 8, 2012
PubMed
Summary

Behçet's syndrome (BS) is a complex disease that doesn't fit neatly into existing categories like autoimmune or autoinflammatory diseases. Its varied symptoms and genetic factors suggest multiple underlying pathological pathways are involved.

More Related Videos

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

Related Experiment Videos

Last Updated: May 21, 2026

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

Area of Science:

  • Rheumatology
  • Immunology
  • Genetics

Background:

  • Behçet's syndrome (BS) is a disease of unknown etiology.
  • Current classification efforts struggle to place BS within established nosological categories such as seronegative spondarthritides, autoimmune, or autoinflammatory diseases.
  • BS can present challenges in differentiation from other conditions, notably Crohn's disease, particularly with intestinal ulceration.

Purpose of the Study:

  • To explore the complex nature of Behçet's syndrome.
  • To discuss the challenges in classifying BS within current medical frameworks.
  • To highlight the evidence suggesting multiple pathological pathways in BS.

Main Methods:

  • Review of existing literature on Behçet's syndrome.
  • Analysis of clinical presentation, regional variations, and genetic components.
  • Examination of differential diagnosis and treatment responses.

Main Results:

  • BS exhibits significant regional variations in disease expression (e.g., intestinal, ocular, skin manifestations).
  • Familial cases show symptom clustering (e.g., acne/arthritis), suggesting multifactorial etiology.
  • Genetic complexity and differing organ responses to therapies (e.g., anti-TNF agents) support the involvement of multiple pathological pathways.

Conclusions:

  • Behçet's syndrome likely involves more than one pathological pathway.
  • The complex genetic component and varied clinical manifestations necessitate a nuanced understanding beyond current classifications.
  • Further research is required to elucidate the distinct pathways contributing to BS heterogeneity.